Inhibitory Activity of Plant Stilbenoids against Nitric Oxide Production by Lipopolysaccharide-Activated Microglia

被引:36
|
作者
Nassra, Merian [1 ]
Krisa, Stephanie [1 ]
Papastamoulis, Yorgos [1 ]
Kapche, Gilbert Deccaux [1 ]
Bisson, Jonathan [1 ]
Andre, Caroline [2 ]
Konsman, Jan-Pieter [2 ]
Schmitter, Jean-Marie [2 ]
Merillon, Jean-Michel [1 ]
Waffo-Teguo, Pierre [1 ]
机构
[1] Univ Bordeaux, Inst Sci Vigne & Vin, Grp Etud Subst Vegetales Activite Biol, F-33882 Villenave Dornon, France
[2] Univ Bordeaux, Bordeaux, France
关键词
stilbenoids; nitric oxide; microglia; polyphenol; anti-inflammatory; INDUCED NO PRODUCTION; RAW-264.7; MACROPHAGES; MOLECULAR-MECHANISMS; RESVERATROL; INFLAMMATION; RESPONSES; DISEASE; CELLS; P38;
D O I
10.1055/s-0032-1328651
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Microglia-driven inflammatory processes are thought to play an important role in ageing and several neurological disorders. Since consumption of a diet rich in polyphenols has been associated with anti-inflammatory and neuroprotective effects, we studied the effects of twenty-five stilbenoids isolated from Milicia excelsa, Morus alba, Gnetum africanum, and Vitis vinifera. These compounds were tested at 5 and 10 mu M on BV-2 microglial cells stimulated with bacterial lipopolysaccharide. Ten stilbenoids reduced lipopolysaccharide-induced nitric oxide production at 5 and/or 10 mu M. Two tetramers, E-vitisin A and E-vitisin B, were the most effective molecules. Moreover, they attenuated the expression of the inducible NO synthase protein and gene.
引用
收藏
页码:966 / 970
页数:5
相关论文
共 50 条
  • [11] Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysaccharide-activated C6 microglia
    Kim, Young Ae
    Kim, Gi-Young
    Park, Kun-Young
    Choi, Yung Hyun
    JOURNAL OF MEDICINAL FOOD, 2007, 10 (02) : 218 - 224
  • [12] Effect of Thalidomide on Nitric Oxide Production in Lipopolysaccharide-activated RAW 264.7 Cells
    Park, Eunkyue
    Levis, William K.
    Greig, Nigel
    Jung, Euisun
    Schuller-Levis, Georgia
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (04) : 330 - 333
  • [13] Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia
    Lau, Francis C.
    Bielinski, Donna F.
    Joseph, James A.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2007, 85 (05) : 1010 - 1017
  • [14] Effect of naturally occurring organosulfur compounds on nitric oxide production in lipopolysaccharide-activated macrophages
    Ippoushi, K
    Itou, H
    Azuma, K
    Higashio, H
    LIFE SCIENCES, 2002, 71 (04) : 411 - 419
  • [15] Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages
    Matsuda, H
    Kageura, T
    Morikawa, T
    Toguchida, I
    Harima, S
    Yoshikawa, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (04) : 323 - 327
  • [16] TIAZOFURIN MODULATES LIPOPOLYSACCHARIDE-ACTIVATED MICROGLIA IN VITRO
    Savic, Danijela
    Lavrnja, Irena
    Dacic, Sanja
    Bjelobaba, Ivana
    Nedeljkovic, Nadezda
    Stojiljkovic, Mirjana
    Herdegen, Thomas
    Pekovic, Sanja
    ARCHIVES OF BIOLOGICAL SCIENCES, 2014, 66 (04) : 1633 - 1640
  • [17] Inhibitory effects of diallyl disulfide on the production of inflammatory mediators and cytokines in lipopolysaccharide-activated BV2 microglia
    Park, Hye Young
    Kim, Nam Deuk
    Kim, Gi-Young
    Hwang, Hye Jin
    Kim, Byung-Woo
    Kim, Wun Jae
    Choi, Yung Hyun
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 262 (02) : 177 - 184
  • [18] Inhibitors from the rhizomes of Alpinia officinarum on production of nitric oxide in lipopolysaccharide-activated macrophages and the structural requirements of diarylheptanoids for the activity
    Matsuda, H
    Ando, S
    Kato, T
    Morikawa, T
    Yoshikawa, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (01) : 138 - 142
  • [19] Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages
    Matsuda, H
    Kageura, T
    Oda, M
    Morikawa, T
    Sakamoto, Y
    Yoshikawa, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (06) : 716 - 720